Our holistic approach integrates high-quality medications, the latest technology, and individualized counseling to devise a plan specifically crafted for your individual health needs and obstacles
Lipo-B12 is a powerful add-on for the right patients
On December 11, 2024, the company initiated its first Phase III trial, GZR18-BWM-301, for its long-acting GLP-1 receptor agonist GZR18 injection
Coverage for obesity treatment varies by state, with only about 18 states offering some form of GLP-1 coverage for weight management as of 2026
Ferritinophagy, a ferritin degradation pathway, depends on NCOA4 (Lin et al., 2020), a selective cargo receptor for the autophagic turnover of ferritin by lysosomes (Mancias et al., 2014)
Resolution of operational challenges, most notably the alleviation of US supply constraints, stabilized product availability, further paving the way for accelerated market growth and greater patient access